Illumina Reports Its Q1 Results on Thursday: 3 Things You Can Expect

Illumina's (NASDAQ: ILMN) planned acquisition of Pacific Biosciences of California ("PacBio") hit a snag recently with the decision by regulators in the United Kingdom to investigate the transaction. You can count on this being a major topic of discussion when Illumina provides its first-quarter update on Thursday, April 25, after the market closes.